Filing Details
- Accession Number:
- 0001179110-18-005784
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-18 17:51:26
- Reporting Period:
- 2018-01-16
- Accepted Time:
- 2018-04-18 17:51:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1194185 | M Armin Kessler | 8 Sylvan Way Parsippany NJ 07054 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-01-16 | 10,000 | $27.37 | 140,993 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-04-16 | 10,000 | $30.05 | 130,993 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on August 30, 2017, which establishes certain dates for stock sales by the reporting person.
- The range of prices for the transactions reported on this line is between $27.07 and $27.81 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Includes 3,000 shares of common stock held by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of his indirect pecuniary interest therein.
- The range of prices for the transactions reported on this line is between $29.82 and $30.50 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.